GenMont Biotech Inc
TWSE:3164
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
GenMont Biotech Inc
TWSE:3164
|
TW |
|
Green Bridge Metals Corp
F:J48
|
CA |
|
A
|
Altus SA
WSE:ALI
|
PL |
|
P
|
Passus SA
WSE:PAS
|
PL |
|
Hotel Grand Central Ltd
SGX:H18
|
SG |
|
Ibstock PLC
LSE:IBST
|
UK |
|
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
TW |
|
Reliable Ventures India Ltd
BSE:532124
|
IN |
|
M
|
Mastercraft Boat Holdings Inc
F:1SG
|
US |
|
Dateline Resources Ltd
OTC:DTREF
|
AU |
|
Harvest Minerals Ltd
F:7HM
|
AU |
|
I
|
Island Concepts Indonesia Tbk PT
IDX:ICON
|
ID |
|
Polibeli Group Ltd
NASDAQ:PLBL
|
ID |
|
F
|
First Industrial Realty Trust Inc
F:F5W
|
US |
|
D
|
Docebo Inc
NASDAQ:DCBO
|
CA |
|
G
|
Gencurix Inc
KOSDAQ:229000
|
KR |
|
Hakuyosha Co Ltd
TSE:9731
|
JP |
|
Huazhu Group Ltd
HKEX:1179
|
CN |
|
L
|
Legal & General Group PLC
F:LGI
|
UK |
|
S
|
Single Well Industrial Corp
TPEX:3490
|
TW |
|
C
|
Cobalt Blue Holdings Ltd
OTC:CBBHF
|
AU |
|
Macmahon Holdings Ltd
ASX:MAH
|
AU |
|
Medartis Holding AG
SIX:MED
|
CH |
|
S
|
Swire Pacific Ltd
XMUN:SWI
|
HK |
Bankruptcy Probability
GenMont Biotech Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
GenMont Biotech Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TW |
|
GenMont Biotech Inc
TWSE:3164
|
1.5B TWD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
484.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
223.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
183.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
122.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
86.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
GenMont Biotech Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, GenMont Biotech Inc has total debt of 125m TWD. This includes both short-term (44.5m TWD) and long-term (80.6m TWD) debt.
You can find a full breakdown on its Balance Sheet.